GS
Glen Santangelo Barclays Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
54
Avg Return
Past Year
Past Year
2.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
66.7%
Neutral
24.1%
Negative
9.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Consumer Discretionary
Healthcare
Industrials
Technology
Communication Services
Internet Content & Information
Consumer Discretionary
Leisure
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Consulting Services
Specialty Business Services
Technology
Software - Application
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $86 |
9%
upside
| 1 | +2.8% |
0
%
| 9 Dec ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $30 |
27%
upside
| 1 | +6.7% |
0
%
| 9 Dec ‘25 4 months ago |
|
|
|
Underweight
Initiated
| $12 |
4%
downside
| 1 | -5% |
0
%
| 9 Dec ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $100 |
24%
upside
| 1 | -12% |
0
%
| 9 Dec ‘25 4 months ago |
|
|
|
Equal-Weight
Initiated
| $30 |
31%
upside
| 1 | – |
–
| 9 Dec ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $15 |
8%
upside
| 1 | +1.3% |
0
%
| 9 Dec ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $49 |
32%
upside
| 1 | -9.5% |
0
%
| 9 Dec ‘25 4 months ago |
|
|
|
Underweight
Initiated
| $5 |
39%
upside
| 1 | +34% |
0
%
| 9 Dec ‘25 4 months ago |
|